1. Home
  2. STKL vs ABUS Comparison

STKL vs ABUS Comparison

Compare STKL & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKL
  • ABUS
  • Stock Information
  • Founded
  • STKL 1973
  • ABUS 2005
  • Country
  • STKL United States
  • ABUS United States
  • Employees
  • STKL N/A
  • ABUS N/A
  • Industry
  • STKL Precious Metals
  • ABUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKL Basic Materials
  • ABUS Health Care
  • Exchange
  • STKL Nasdaq
  • ABUS Nasdaq
  • Market Cap
  • STKL 694.7M
  • ABUS 611.0M
  • IPO Year
  • STKL N/A
  • ABUS N/A
  • Fundamental
  • Price
  • STKL $6.26
  • ABUS $3.13
  • Analyst Decision
  • STKL Strong Buy
  • ABUS Strong Buy
  • Analyst Count
  • STKL 2
  • ABUS 4
  • Target Price
  • STKL $9.50
  • ABUS $5.50
  • AVG Volume (30 Days)
  • STKL 803.4K
  • ABUS 869.3K
  • Earning Date
  • STKL 08-06-2025
  • ABUS 07-31-2025
  • Dividend Yield
  • STKL N/A
  • ABUS N/A
  • EPS Growth
  • STKL N/A
  • ABUS N/A
  • EPS
  • STKL N/A
  • ABUS N/A
  • Revenue
  • STKL $740,934,000.00
  • ABUS $6,403,000.00
  • Revenue This Year
  • STKL $10.78
  • ABUS $3.35
  • Revenue Next Year
  • STKL $8.39
  • ABUS N/A
  • P/E Ratio
  • STKL N/A
  • ABUS N/A
  • Revenue Growth
  • STKL 12.92
  • ABUS N/A
  • 52 Week Low
  • STKL $3.65
  • ABUS $2.71
  • 52 Week High
  • STKL $8.11
  • ABUS $4.73
  • Technical
  • Relative Strength Index (RSI)
  • STKL 56.23
  • ABUS 41.34
  • Support Level
  • STKL $6.15
  • ABUS $3.11
  • Resistance Level
  • STKL $6.66
  • ABUS $3.36
  • Average True Range (ATR)
  • STKL 0.28
  • ABUS 0.13
  • MACD
  • STKL 0.03
  • ABUS -0.01
  • Stochastic Oscillator
  • STKL 56.99
  • ABUS 19.78

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: